Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 9476 Neoplasms 6587 Prostatic Neoplasms 4399 Colorectal Neoplasms 3977 Lung Neoplasms 3642 Carcinoma, Non-Small-Cell Lung 3583 Pancreatic Neoplasms 2478 Carcinoma, Hepatocellular 2411 Leukemia, Myeloid, Acute 2265 Multiple Myeloma 2120 Stomach Neoplasms 2108 Neoplasm Metastasis 1911 Head and Neck Neoplasms 1869 Ovarian Neoplasms 1773 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1734 Lymphoma 1729 Brain Neoplasms 1699 Rectal Neoplasms 1676 Melanoma 1654 Colonic Neoplasms 1629 Leukemia 1500 Uterine Cervical Neoplasms 1499 Recurrence 1485 Esophageal Neoplasms 1311 Glioblastoma 1307 Lymphoma, Non-Hodgkin 1204 Leukemia, Lymphocytic, Chronic, B-Cell 1120 Squamous Cell Carcinoma of Head and Neck 1109 Urinary Bladder Neoplasms 1078 Lymphoma, Follicular 1067

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Cystic Neoplasm × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡